The Oncology Institute (NASDAQ: TOI ) is a company bringing together cancer care practices around the United States. Their main focus is to reduce costs related to oncological treatments and cancer patient management. Their services encompass patient services toAt ELAM1, we empower financial professionals and investors with the scientific and clinical expertise required to navigate the complexities of the healthcare sector. By bridging the gap between cutting-edge science and financial strategy, we help our ...

文章核心观点 美国最大的价值型肿瘤治疗集团之一的肿瘤研究所（TOI）宣布其首席执行官Daniel Virnich博士和首席财务官Rob Carter将于2025年5月21日参加在加州玛丽娜德尔雷举行的B. Riley第25届年度机构投资者会议 [1] 公司介绍 - 公司成立于2007年，致力于在社区环境中提供高度专业化、价值型癌症治疗服务，推动肿瘤学发展 [2] - 为超180万患者提供前沿、循证癌症治疗，包括临床试验、输血等传统上与最先进医疗服务机构相关的服务 [2] - 拥有超120名执业临床医生和超700名员工，分布在70多个诊所 [2] 联系方式 - 媒体联系邮箱为marketing@theoncologyinstitute.com [3] - 投资者联系邮箱为investors@theoncologyinstitute.com [3] - 公司官网为www.theoncologyinstitute.com [3]